Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference
Rhea-AI Summary
Integra LifeSciences (Nasdaq:IART) announced that Bob Davis, executive vice president and president Tissue Reconstruction, will present at the 2026 Truist Securities MedTech Conference on June 16, 2026, at 3:00pm ET.
A live webcast of the presentation will be available on the company’s investor relations website under Events & Presentations.
Positive
- None.
Negative
- None.
News Market Reaction – IART
On the day this news was published, IART declined 1.74%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 02 | Conference appearance | Neutral | +0.0% | Jefferies Global Healthcare Conference presentation with live webcast access. |
| May 08 | Conference appearance | Neutral | +2.6% | BofA Securities 2026 Health Care Conference investor presentation announcement. |
| May 05 | Leadership change | Positive | +24.1% | Appointment of Stuart Essig as CEO and Michael McBreen as chief commercial officer. |
| May 05 | Earnings release | Positive | +24.1% | Q1 2026 results with adjusted EPS guidance raised and revenue guidance reaffirmed. |
| Apr 20 | Earnings call notice | Neutral | +0.2% | Announcement of timing and access details for Q1 2026 earnings call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Conference appearance announcements have generally had limited impact, while leadership and earnings news coincided with strong positive moves.
Over the last few months, Integra LifeSciences has frequently communicated with investors through conferences and financial updates. A leadership transition and Q1 2026 results on May 5, 2026 coincided with a 24.13% move, alongside reaffirmed revenue guidance and higher adjusted EPS guidance. By contrast, prior conference participation announcements on May 8, 2026 and June 2, 2026 saw modest or flat reactions, framing today’s Truist MedTech appearance as part of an ongoing investor outreach cadence.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice president and president Tissue Reconstruction will present at the 2026 Truist Securities MedTech Conference on June 16, 2026 at 3:00pm ET.
A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.
About Integra LifeSciences
Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies are trusted by healthcare professionals to deliver life-saving care. For our latest news and information, visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
Integra LifeSciences Holdings Corporation
